DHT and Hair Loss: The Science Behind Androgenetic Alopecia in NYC
Androgenetic alopecia—commonly called male or female pattern hair loss—affects approximately 50 million men and 30 million women in the United States. At its core, this condition is driven by a single molecule: dihydrotestosterone (DHT). Understanding how DHT interacts with your hair follicles is the first step toward effective treatment.
At Regen Health Physicians NYC, Dr. Ajit Dhaliwal uses regenerative medicine approaches to address androgenetic alopecia at its biological root—not just mask its symptoms.
What Is DHT and Why Does It Cause Hair Loss?
DHT is a potent androgen derived from testosterone through the action of an enzyme called 5-alpha reductase. While DHT plays important roles in development and male physiology, genetically susceptible hair follicles on the scalp respond to it with progressive miniaturization.
Here is what happens at the follicular level:
- DHT binds to androgen receptors within the dermal papilla cells of the hair follicle
- This binding triggers a cascade of inflammatory and fibrotic signals
- The anagen (growth) phase of the hair cycle shortens progressively
- Follicles produce thinner, shorter hairs over successive cycles
- Eventually, follicles enter a permanent dormant state
The pattern of involvement—frontal recession and crown thinning in men, diffuse central thinning in women—reflects the density of androgen receptors in those scalp regions.
The Genetic Component
Androgenetic alopecia is a polygenic condition. While the androgen receptor gene on the X chromosome contributes, multiple autosomal genes also influence susceptibility. This explains why the condition can be inherited from either parent and why severity varies widely among individuals with family histories of hair loss.
Genetic testing can offer some predictive information, but it does not yet provide clinically actionable detail beyond what a careful history and physical examination reveal.
How Regenerative Medicine Addresses DHT-Mediated Follicle Damage
Conventional treatments such as minoxidil and finasteride target DHT activity or improve blood flow but do not directly repair follicular tissue that has already been damaged. Regenerative approaches offer something different.
Platelet-Rich Plasma (PRP) Therapy
PRP hair restoration uses a concentrated preparation of your own platelets—which contain growth factors including PDGF, VEGF, and TGF-β—to:
- Stimulate dormant follicle stem cells in the bulge region
- Reduce perifollicular inflammation driven by DHT exposure
- Extend the anagen phase of the hair cycle
- Improve blood supply to the dermal papilla
Multiple controlled trials support PRP's effectiveness in androgenetic alopecia, with studies showing significant increases in hair density and thickness after a series of treatments.
Microneedling with PRP
Combining microneedling with PRP creates microchannels in the scalp dermis, enhancing PRP absorption while independently activating wound healing pathways that stimulate follicular regeneration. This combination is particularly effective for patients with moderate alopecia who retain viable follicles.
Addressing the Inflammatory Microenvironment
Emerging research highlights the role of scalp inflammation in perpetuating follicle miniaturization. DHT-driven prostaglandin D2 (PGD2) upregulation contributes to follicular inhibition. Anti-inflammatory peptides and targeted regenerative protocols help normalize the scalp microenvironment, creating conditions more favorable for follicle survival and recovery.
What to Expect at RHPNY
Your initial consultation at Regen Health Physicians includes a thorough assessment of hair density using trichoscopy, a review of hormonal and metabolic factors that may be contributing to loss, and a customized treatment plan.
For most patients with androgenetic alopecia, we recommend:
- A series of three to four PRP treatments spaced four to six weeks apart
- A maintenance protocol every three to six months
- Supportive measures including nutritional optimization and, where appropriate, DHT-reducing agents
The earlier treatment begins, the better the outcome—follicles that have miniaturized but retain some viability respond far better than those in prolonged dormancy.
Candidacy Considerations
PRP-based regenerative hair restoration is most effective when:
- Hair loss is in the early to moderate stage (Norwood II–IV in men, Ludwig I–II in women)
- The patient has realistic expectations about hair density improvement
- Platelet counts are adequate (assessed via a simple blood test)
- Hormonal contributions (thyroid dysfunction, elevated SHBG, iron deficiency) have been addressed
Patients with advanced alopecia and extensive scarring of the follicular unit may be better served by hair transplantation consultation, though PRP can still optimize graft survival.
When to Seek Evaluation
If you are noticing progressive hair thinning, increased shedding, or a widening part, early evaluation allows for the most treatment options. At RHPNY, we take a precision medicine approach—identifying the contributing factors unique to your biology rather than applying a one-size-fits-all protocol.
Schedule a consultation to discuss whether regenerative hair restoration is right for your situation.
---
This article is intended for educational purposes. Individual results from PRP and regenerative hair restoration vary. Dr. Ajit Dhaliwal and the RHPNY team will evaluate your specific medical history and candidacy at your consultation. This content does not constitute medical advice.
